SCHEMBL3310508

SCHEMBL3310508

COc1ccc(F)c(C(=O)C=C(O)C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CPS1 P31327 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.41
MEN1 O00255 2/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
ALOX12 P18054 1/20 0.41
CTSL P07711 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3310505 1.00 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10CPS1SMN1; SMN2
SCHEMBL3310499 1.00 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10CPS1SMN1; SMN2
SCHEMBL3310998 0.88 MEN1 (0.53) ALDH1A1TSHRHSD17B10CPS1ABCG2
SCHEMBL3311002 0.88 MEN1 (0.53) ALDH1A1TSHRHSD17B10CPS1ABCG2
SCHEMBL3310996 0.88 MEN1 (0.53) ALDH1A1TSHRHSD17B10CPS1ABCG2
SCHEMBL8426128 0.82 MAPT (0.49) ALDH1A1CPS1SMN1; SMN2ABCG2MEN1
Water SCHEMBL9265170 0.81 MAPT (0.47) ALDH1A1CPS1SMN1; SMN2ABCG2MEN1
SCHEMBL3310540 0.79 CES2 (0.55) ALDH1A1
SCHEMBL3310538 0.79 CES2 (0.55) ALDH1A1
SCHEMBL3310535 0.79 CES2 (0.55) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 ALDH1A1 620/4885TSHR 3121/4885HSD17B10 189/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 ALDH1A1 620/4885TSHR 3121/4885HSD17B10 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.